Overall survival and prognostic factors of oral cavity and oropharyngeal squamous cell carcinomas in Saudi Arabia: a population-based cohort study (2000–2019) - Report - MDSpire

Overall survival and prognostic factors of oral cavity and oropharyngeal squamous cell carcinomas in Saudi Arabia: a population-based cohort study (2000–2019)

  • By

  • Waad R. Al-Amri

  • Abdullah S. Al-Swuailem

  • June 11, 2026

  • 0 min

Share

Survival Rates and Prognostic Indicators for Oral Cavity and Oropharyngeal SCC

Overview

This study evaluates overall survival rates and prognostic factors for oral cavity and oropharyngeal squamous cell carcinomas in Saudi Arabia from 2000 to 2019. The findings indicate a 5-year overall survival of 55% for OC-SCC and 49% for OP-SCC, with significant variations based on stage at diagnosis and demographic factors.

Background

Oral cavity and oropharyngeal cancers are significant contributors to head and neck cancer mortality globally. Understanding survival patterns and prognostic indicators in specific populations, such as Saudi Arabia, is crucial for improving early detection and treatment strategies. This study addresses the gap in long-term survival data for these cancers in the region.

Data Highlights

{'aHR': 'adjusted Hazard Ratio'}

Key Findings

{'confidence_intervals': 'Include confidence intervals for all aHR values.'}

Clinical Implications

The findings emphasize the need for early detection and improved access to cancer care to enhance survival outcomes for OC-SCC and OP-SCC. Clinicians should consider demographic factors and stage at diagnosis when assessing prognosis and treatment options for patients.

Conclusion

Survival outcomes for oral cavity and oropharyngeal squamous cell carcinomas in Saudi Arabia are modest, highlighting the importance of early detection and equitable healthcare access to improve patient outcomes.

Related Resources & Content

  1. Frontiers in Oncology, 2026 -- Comparative molecular analysis of colorectal cancer in Saudi Arabia: distinct genetic alterations and clinical features
  2. the asco post, 2025 -- Oropharyngeal Cancer in the United States: Recent Estimates and Future Trends
  3. Journal of the American Dental Association, 2026 -- Light-based adjuncts to determine the need for biopsy for early detection of oral squamous cell carcinoma and potentially malignant disorders: An evidence summary of a living systematic review, Version 2026 1.0
  4. Frontiers in Oncology, 2026 -- Predicting survival in oral squamous cell carcinoma via integrated analysis of tumor budding and tertiary lymphoid structures
  5. AJCC Current Staging System, 2026 -- Current Staging System
  6. Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial - PMC
  7. Prognostic Factors in Oral Squamous Cell Carcinoma: Systematic Review and Meta‐Analysis - González‐Ruiz, 2025 - Oral Diseases - Wiley Online Library
  8. AJCC Current Staging System
  9. Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial - PMC
  10. Prognostic Factors in Oral Squamous Cell Carcinoma: Systematic Review and Meta‐Analysis - González‐Ruiz - 2025 - Oral Diseases - Wiley Online Library

Original Source(s)

Related Content